CDKN2A Determines Mesothelioma Cell Fate to EZH2 Inhibition

Giulia Pinton(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”), Laura Moro(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”)
Frontiers in Oncology
July 1, 2021
10.3389/fonc.2021.678447
Cited by 16

Related Papers

Integrin-induced Epidermal Growth Factor (EGF) Receptor Activation Requires c-Src and p130Cas and Leads to Phosphorylation of Specific EGF Receptor Tyrosines
|Journal of Biological Chemistry|2002|375
Estrogen Receptor β Exerts Tumor Repressive Functions in Human Malignant Pleural Mesothelioma via EGFR Inactivation and Affects Response to Gefitinib
|PLoS ONE|2010|58
PARP1 inhibition affects pleural mesothelioma cell viability and uncouples AKT/mTOR axis via SIRT1
|Journal of Cellular and Molecular Medicine|2013|36
Perifosine as a Potential Novel Anti-Cancer Agent Inhibits EGFR/MET-AKT Axis in Malignant Pleural Mesothelioma
|PLoS ONE|2012|36
Agonist activation of estrogen receptor beta (ERβ) sensitizes malignant pleural mesothelioma cells to cisplatin cytotoxicity
|Molecular Cancer|2014|24